Cardioprotective Effects of Astragalin against Myocardial Ischemia/Reperfusion Injury in Isolated Rat Heart

Figure 3

(a–e) Representatively histopathological observations of the heart (bar = 100 μm). HE staining (×200). (a) Normal architecture of myocardium in the control group. (b) Architecture of myocardium in the I/R group. (c–e) Architecture of myocardium in the astragalin groups (pretreated with 5, 10, and 20 μmol/L of astragalin).

(a)

(b)

(c)

(d)

(e)